Skip to main content
Premium Trial:

Request an Annual Quote

NIH Commits $14M to Fund Biomedical Informatics, Data Science Training Programs

NEW YORK (GenomeWeb) – The National Institutes of Health announced that it is earmarking $14 million in fiscal 2017 to support grant awards under the National Library of Medicine (NLM) Institutional Training Program in Biomedical Informatics and Data Science.

The program was established to support biomedical informatics training at educational institutions across the US. According to the NIH, NLM's training programs are designed to meet the growing need for investigators trained in biomedical computing, data science, and related information fields as they relate to applications in health and biomedicine.

NLM-supported programs are expected to train researchers to conduct original basic or applied research, and to be prepared for research-oriented roles at academic institutions, non-profit research organizations, and healthcare organizations.

Through the newly announced funding opportunity, the NIH said that it intends to fund between 14 and 17 applications proposing training programs in one or more of the following areas: healthcare/clinical informatics; translational bioinformatics; clinical research informatics; and public health informatics. Programs focused on informatics and data science in the study of environmental exposures will also be considered.

Training programs should be geared toward predoctoral and postdoctoral students seeking careers in research, and are expected to run for five years. While the NIH intends to commit $14 million to fund selected programs in fiscal 2017, future year amounts will depend on annual appropriations

Additional details about the funding opportunity can be found here.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.